I-MAB (IMAB)
1.76
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.77
+0.01
(+0.57%)
After-Hours: 20:00
I-MAB EPS Diluted (Quarterly)
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 2.191 |
| September 30, 2020 | 0.093 |
| December 31, 2019 | -0.9368 |
| Date | Value |
|---|---|
| September 30, 2019 | -0.6064 |
| December 31, 2018 | -0.401 |
| September 30, 2018 | -0.3718 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.9368
Minimum
Dec 2019
2.191
Maximum
Dec 2020
0.1852
Average
-0.2567
Median
EPS Diluted (Quarterly) Benchmarks
| Zai Lab Ltd | -1.00 |
| WuXi Biologics (Cayman) Inc | -- |
| Wuxi AppTec Co Ltd | 0.0922 |
| Gracell Biotechnologies Inc (DELISTED) | -0.1106 |
| Sinovac Biotech Ltd | -- |
EPS Diluted (Quarterly) Related Metrics
| Enterprise Value | -167.41M |
| Earnings Yield | -141.1% |
| Normalized Earnings Yield | -141.05 |